Innovative FEED Act of 2025
- Sponsor
- Sen. Marshall, Roger [R-KS]
- Committees
- Agriculture, Nutrition, and Forestry Committee (primary)
- Last action
- May 22, 2025
Bottom line
The Innovative FEED Act of 2025 establishes a distinct regulatory pathway under the FDA for novel animal feed ingredients that modify gut function or reduce pathogens, aiming to foster innovation while maintaining safety standards.
What it actually does
This bill amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to create a new regulatory category for "zootechnical animal food substances." These substances are defined as those added to animal food or water to affect digestive byproducts, reduce foodborne pathogens, or alter the gastrointestinal microbiome to impact an animal's structure or function, provided they act solely within the gastrointestinal tract. The bill clarifies that these substances are to be regulated as food additives, not drugs, and establishes specific requirements for their approval and labeling.
Proponents argue
Supporters argue that this bill provides much-needed regulatory clarity and a streamlined pathway for innovative animal feed products that can improve animal health, enhance food safety by reducing pathogens, and boost the efficiency and sustainability of animal agriculture. They contend that the current regulatory framework is ill-suited for these substances, hindering their development and adoption, and that this bill appropriately distinguishes them from animal drugs.
Opponents contend
Critics might express concerns that creating a new category, even with specific exclusions, could inadvertently create loopholes or lead to less rigorous oversight compared to drug approval processes. They may argue that the distinction between affecting animal function and preventing disease could become blurred in practice, potentially allowing substances with drug-like effects to enter the market with a lower bar for approval, impacting animal welfare or public health.
The bill is short and focused, making it accessible for a quick read and evaluation by an informed reader.
Section 2(a), amending Section 201 of the FFDCA
Definition of 'Zootechnical Animal Food Substance'
This provision introduces a new definition for 'zootechnical animal food substance' (ZAFS) into federal law. It specifies that these are substances added to animal food or water that are intended to affect an animal's digestive process byproducts, reduce foodborne pathogens of human health significance, or alter the animal's gastrointestinal microbiome to affect its body structure or function (excluding nutritive value). Crucially, these substances must act *solely within the gastrointestinal tract* and are explicitly deemed food additives, not drugs, for regulatory purposes.
Supporters argue
Proponents argue that this definition is essential for regulatory clarity, allowing the FDA to properly evaluate and approve these innovative products without forcing them into an inappropriate drug classification. They believe it will spur research and development in animal nutrition and health.
Critics contend
Opponents might contend that the distinction between 'affecting function' and 'preventing disease' could be ambiguous in practice, potentially leading to substances with therapeutic effects being regulated with less scrutiny than traditional animal drugs. They may worry about the long-term implications of such a reclassification.
Tradeoffs
The provision balances the desire for innovation in animal agriculture with the need for robust safety and efficacy oversight. The tension lies in drawing a clear, enforceable line between a 'food additive' that affects function and an 'animal drug' that treats or prevents disease.
Section 2(b), amending Section 409 of the FFDCA
Food Additive Petition Requirements and Labeling for ZAFS
This section modifies the process for approving food additive petitions specifically for zootechnical animal food substances. It requires petitioners to submit all relevant data on the intended effect and quantity needed, along with full investigation reports. It also allows the Secretary to establish conditions of use to ensure the substance achieves its intended effect. Furthermore, it mandates specific labeling for ZAFS, requiring a statement: 'Not for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in animals,' while permitting claims about the substance's intended effect on animal body structure or function.
This subsection explicitly excludes several categories of substances from the definition of a 'zootechnical animal food substance.' These exclusions include substances intended for disease diagnosis, cure, mitigation, treatment, or prevention; hormones; active moieties in already approved/indexed animal drugs; and ionophores. It also allows the Secretary to exclude other substances via rulemaking.
Section 2(a), amending Section 201(tt)(2) of the FFDCA
Why it matters:These exclusions are standard legislative practice to prevent overlap with existing regulatory categories and ensure clarity on what the new definition *does not* cover. It's crucial for preventing the reclassification of known drugs or other regulated substances.
Case for: Supporters argue that these exclusions are vital to prevent regulatory arbitrage, ensuring that substances already regulated as drugs or hormones do not bypass their established, often more stringent, approval pathways. This maintains the integrity of existing regulatory frameworks.
Case against: No specific opposition is typically raised against these exclusions as they serve to clarify the scope and prevent unintended consequences. Any opposition would likely focus on whether the exclusions are broad enough or if the 'solely within the gastrointestinal tract' clause is sufficiently robust.
Estimated impact: Prevents the reclassification of a significant number of existing animal health products, maintaining their current regulatory status and ensuring the new pathway is for truly novel substances.
This section includes a 'Rule of Construction' stating that nothing in the Act, or its amendments, shall be construed to authorize the Secretary of Health and Human Services to require the use of any zootechnical food substance or food additive.
Section 2(d)
Why it matters:This is a common legislative safeguard to prevent misinterpretation of regulatory authority. It ensures that the FDA's power to *approve* substances does not extend to *mandating* their use, addressing potential concerns about government overreach in agricultural practices.
Case for: Proponents argue this clause is important for protecting the autonomy of agricultural producers and ensuring that the government's role remains one of regulation and safety, not dictating farming methods. It reassures stakeholders that the bill is not a step towards mandatory adoption of certain feed additives.
Case against: No direct opposition to this specific rule of construction is expected, as it reaffirms a widely accepted principle of regulatory authority. It is a protective measure rather than a controversial policy change.
Estimated impact: Ensures that the adoption of approved zootechnical animal food substances remains voluntary for producers, preserving market choice and farm management decisions.